| scholarly article | Q13442814 |
| P2093 | author name string | V Rossi | |
| T Liu | |||
| A Biondi | |||
| J Schwaller | |||
| D Jankovic | |||
| F Baty | |||
| S Ehret | |||
| L Brault | |||
| V Stavropoulou | |||
| P2860 | cites work | Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study | Q24643738 |
| MN1, a novel player in human AML | Q24653588 | ||
| MN1-TEL myeloid oncoprotein expressed in multipotent progenitors perturbs both myeloid and lymphoid growth and causes T-lymphoid tumors in mice | Q24669642 | ||
| Conditional MN1-TEL knock-in mice develop acute myeloid leukemia in conjunction with overexpression of HOXA9 | Q24669668 | ||
| High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients | Q28209409 | ||
| MLL translocations, histone modifications and leukaemia stem-cell development | Q29615368 | ||
| Candidate genes for expansion and transformation of hematopoietic stem cells by NUP98-HOX fusion genes | Q33294832 | ||
| Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL | Q33887064 | ||
| Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes | Q33889476 | ||
| MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML. | Q34627288 | ||
| MN1 overexpression is an important step in the development of inv(16) AML. | Q34631634 | ||
| Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors | Q34641731 | ||
| Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells | Q35847760 | ||
| Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis | Q35848246 | ||
| The molecular basis of leukemia | Q35961770 | ||
| Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. | Q36098242 | ||
| ReSETting PP2A tumour suppressor activity in blast crisis and imatinib-resistant chronic myelogenous leukaemia | Q36585748 | ||
| Retroviral insertion mutagenesis in mice as a comparative oncogenomics tool to identify disease genes in human leukemia | Q36681931 | ||
| Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells | Q36726183 | ||
| N-Glycans in cancer progression | Q37243167 | ||
| Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia. | Q39975102 | ||
| Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. | Q40219637 | ||
| Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. | Q40252270 | ||
| Suppressor of cytokine signalling-1 gene silencing in acute myeloid leukaemia and human haematopoietic cell lines | Q40522793 | ||
| Retroviral insertional mutagenesis identifies genes that collaborate with NUP98-HOXD13 during leukemic transformation. | Q42185555 | ||
| AML1 mutations induced MDS and MDS/AML in a mouse BMT model | Q42818187 | ||
| Significance of heat-shock protein (HSP) 90 expression in acute myeloid leukemia cells | Q42970606 | ||
| High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics | Q44034346 | ||
| Prognostically useful gene-expression profiles in acute myeloid leukemia | Q51999490 | ||
| Acute myeloid leukemia induced by MLL-ENL is cured by oncogene ablation despite acquisition of complex genetic abnormalities | Q53315688 | ||
| MN1-TEL, the product of the t(12;22) in human myeloid leukemia, immortalizes murine myeloid cells and causes myeloid malignancy in mice. | Q53344487 | ||
| MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. | Q53362332 | ||
| The MLL recombinome of acute leukemias | Q56965972 | ||
| Significance of murine retroviral mutagenesis for identification of disease genes in human acute myeloid leukemia | Q82310130 | ||
| P433 | issue | 3 | |
| P921 | main subject | collaboration | Q1145523 |
| leukemia | Q29496 | ||
| P304 | page(s) | 601-612 | |
| P577 | publication date | 2010-01-14 | |
| P1433 | published in | Leukemia | Q6534498 |
| P1476 | title | Functional characterization of high levels of meningioma 1 as collaborating oncogene in acute leukemia | |
| P478 | volume | 24 |
| Q35995227 | An insertional mutagenesis screen identifies genes that cooperate with Mll-AF9 in a murine leukemogenesis model |
| Q45990007 | CXCR4-SERINE339 regulates cellular adhesion, retention and mobilization, and is a marker for poor prognosis in acute myeloid leukemia. |
| Q35425688 | Cell fate decisions in malignant hematopoiesis: leukemia phenotype is determined by distinct functional domains of the MN1 oncogene |
| Q38262122 | Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1/AbdB-like HOX protein complex |
| Q34474749 | Cell population-specific expression analysis of human cerebellum |
| Q38981878 | Constitutive IRF8 expression inhibits AML by activation of repressed immune response signaling |
| Q96640393 | Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia |
| Q37818094 | Epigenetic Mechanisms in Acute Myeloid Leukemia |
| Q37499049 | High MN1 expression increases the in vitro clonogenic activity of primary mouse B-cells |
| Q44738170 | Impairing MLL-fusion gene-mediated transformation by dissecting critical interactions with the lens epithelium-derived growth factor (LEDGF/p75). |
| Q34692292 | Mapping of MN1 Sequences Necessary for Myeloid Transformation |
| Q47117304 | Meis2 as a critical player in MN1-induced leukemia. |
| Q46570611 | Meningioma 1 (MN1) expression: Refined risk stratification in acute myeloid leukemia with normal cytogenetics (CN-AML) |
| Q38432673 | Modeling de novo leukemogenesis from human cord blood with MN1 and NUP98HOXD13 |
| Q47255841 | Myeloid neoplasms with t(12;22)(p13;q12)/MN1-EVT6: a systematic review of 12 cases. |
| Q28482247 | Overexpression of MN1 Confers Resistance to Chemotherapy, Accelerates Leukemia Onset, and Suppresses p53 and Bim Induction |
| Q37524210 | Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity |
| Q36036310 | Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction |
| Q94482231 | Role of Meningioma 1 for maintaining the transformed state in MLL-rearranged acute myeloid leukemia: potential for therapeutic intervention? |
| Q30250315 | Significance of oncogenes and tumor suppressor genes in AML prognosis. |
| Q42143905 | The Meningioma 1 (MN1) Gene is an Independent Poor Prognostic Factor in Adult Egyptian Acute Myeloid Leukemia Patients |
| Q51890625 | Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia |
| Q35885311 | Unique dual targeting of thymidylate synthase and topoisomerase1 by FdUMP[10] results in high efficacy against AML and low toxicity |
Search more.